ChatGPT to debut at AACR annual meeting with insights on pharma data for medical professionals

USA — ChatGPT, a large language model trained by OpenAI, is set to debut in the world of medical meetings, starting with the American Association for Cancer Research (AACR) Annual Meeting.

ChatGPT is bringing its expertise in analyzing and understanding pharmaceutical data to provide new insights to medical professionals.

FermaGPT, a novel application from ZoomRx, is a time-efficient tool that can provide quick answers to questions related to medical conference abstracts and clinical findings.

This AI-powered product is being launched for public use, starting with the American Association for Cancer Research (AACR) annual meeting, which is scheduled for April 14-19.

Although ZoomRx also offers bespoke versions of FermaGPT to its paying customers, the new “light” version is freely accessible to everyone at https://aacr23.ferma.ai/#/chat.

While ZoomRx executives have not disclosed the names of its pharmaceutical clients, its Ferma.ai website acknowledges Pfizer, GSK, Bristol Myers Squibb, and Janssen as “trusted by” firms.

According to Ty Harkness, the chief of staff at ZoomRx, Ferma.ai is an improved large language model for pharma use because of additional data sources such as clinicaltrials.gov, pharma and biotech earnings calls, and other sources across life sciences.

They have also created a detailed knowledge graph specific to the pharma industry to train ChatGPT to understand terminology and relationships, making it more pharma intelligent.

The FermaGPT AACR application has the capability to search through all 8,230 submitted abstracts and research to surface specific requests, such as identifying novel KRAS abstracts in NSCLC or summarizing key discussions around racial disparities in prostate cancer.

In addition to an AI-generated response to the user’s query, FermaGPT lists the source material and links below it.

As a prototype launched just after the first AACR abstracts were released, ZoomRx plans to continue adding data and information as they become available.

They have been working on Ferma.ai for five years and have been able to advance rapidly with the availability of large language models like ChatGPT.

ZoomRx plans to create FermaGPT public access applications for most major medical conferences, including AAN, ASCO, ESMO (for both breast cancer in May and the larger conference in October), SABCS, and ASH, as well as many smaller ones.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.